These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 3931911)

  • 1. A bioassay to measure cytotoxicity of plasma from patients treated with mitomycin C.
    Marshall RS; Erlichman C; Rauth AM
    Cancer Res; 1985 Nov; 45(11 Pt 2):5939-43. PubMed ID: 3931911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperthermic enhancement of cell killing by mitomycin C in mitomycin C-resistant Chinese hamster ovary cells.
    Wallner KE; Banda M; Li GC
    Cancer Res; 1987 Mar; 47(5):1308-12. PubMed ID: 3102043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modification of the cytotoxic activity of mitomycin C by oxygen and ascorbic acid in Chinese hamster ovary cells and a repair-deficient mutant.
    Marshall RS; Rauth AM
    Cancer Res; 1986 Jun; 46(6):2709-13. PubMed ID: 3084075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defective removal of DNA cross-links in a repair-deficient mutant of Chinese hamster cells.
    Meyn RE; Jenkins SF; Thompson LH
    Cancer Res; 1982 Aug; 42(8):3106-10. PubMed ID: 6807537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxygen and exposure kinetics as factors influencing the cytotoxicity of porfiromycin, a mitomycin C analogue, in Chinese hamster ovary cells.
    Marshall RS; Rauth AM
    Cancer Res; 1988 Oct; 48(20):5655-9. PubMed ID: 3167822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of mitomycin C for aerobic and hypoxic cells in vitro and in vivo.
    Rauth AM; Mohindra JK; Tannock IF
    Cancer Res; 1983 Sep; 43(9):4154-8. PubMed ID: 6409398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxic potential of monoalkylation products between mitomycins and DNA: studies of decarbamoyl mitomycin C in wild-type and repair-deficient cell lines.
    Rockwell S; Kim SY
    Oncol Res; 1995; 7(1):39-47. PubMed ID: 7549043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxic potential of monoalkylation products between mitomycins and DNA: studies of decarbamoyl mitomycin C in wild-type and repair-deficient cell lines.
    Kim SY; Rockwell S
    Oncol Res; 1995; 7(5):39-47. PubMed ID: 8534933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation of Chinese hamster ovary cell mutants deficient in excision repair and mitomycin C bioactivation.
    Dulhanty AM; Li M; Whitmore GF
    Cancer Res; 1989 Jan; 49(1):117-22. PubMed ID: 2491748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of mitomycin C in humans.
    den Hartigh J; McVie JG; van Oort WJ; Pinedo HM
    Cancer Res; 1983 Oct; 43(10):5017-21. PubMed ID: 6411336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A clinical trial of a new mitomycin C derivative, KW-2083 (7-N-(p-hydroxyphenyl)-mitomycin C)].
    Takahashi K; Yokoyama M; Takahashi H; Wakui A
    Gan To Kagaku Ryoho; 1985 Sep; 12(9):1787-93. PubMed ID: 4037809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, and evaluation of mitomycin-tethered phosphorothioate oligodeoxynucleotides.
    Huh N; Rege AA; Yoo B; Kogan TP; Kohn H
    Bioconjug Chem; 1996; 7(6):659-69. PubMed ID: 8950485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preferential activation of mitomycin C to cytotoxic metabolites by hypoxic tumor cells.
    Kennedy KA; Rockwell S; Sartorelli AC
    Cancer Res; 1980 Jul; 40(7):2356-60. PubMed ID: 7388797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a set of Chinese hamster ovary variant cell lines demonstrating differing sensitivity to mitomycin C.
    Kuehl BL; Buchwald M; Rauth AM
    Oncol Res; 1993; 5(6-7):213-21. PubMed ID: 8123941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formation of a major DNA adduct of the mitomycin metabolite 2,7-diaminomitosene in EMT6 mouse mammary tumor cells treated with mitomycin C.
    Palom Y; Belcourt MF; Kumar GS; Arai H; Kasai M; Sartorelli AC; Rockwell S; Tomasz M
    Oncol Res; 1998; 10(10):509-21. PubMed ID: 10338154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adducts of mitomycin C and DNA in EMT6 mouse mammary tumor cells: effects of hypoxia and dicumarol on adduct patterns.
    Bizanek R; Chowdary D; Arai H; Kasai M; Hughes CS; Sartorelli AC; Rockwell S; Tomasz M
    Cancer Res; 1993 Nov; 53(21):5127-34. PubMed ID: 7693331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of NADPH:cytochrome c reductase and DT-diaphorase in the biotransformation of mitomycin C1.
    Keyes SR; Fracasso PM; Heimbrook DC; Rockwell S; Sligar SG; Sartorelli AC
    Cancer Res; 1984 Dec; 44(12 Pt 1):5638-43. PubMed ID: 6437671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro thermochemotherapy of human colon cancer cells with cis-dichlorodiammineplatinum(II) and mitomycin C.
    Barlogie B; Corry PM; Drewinko B
    Cancer Res; 1980 Apr; 40(4):1165-8. PubMed ID: 7188883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NRH:quinone oxidoreductase 2 (NQO2) catalyzes metabolic activation of quinones and anti-tumor drugs.
    Celli CM; Tran N; Knox R; Jaiswal AK
    Biochem Pharmacol; 2006 Jul; 72(3):366-76. PubMed ID: 16765324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability of mitomycin admixtures.
    Quebbeman EJ; Hoffman NE; Ausman RK; Hamid AA
    Am J Hosp Pharm; 1985 Aug; 42(8):1750-4. PubMed ID: 4036973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.